Strategic Options on Behalf of Patients with Metastatic Colorectal Cancer: Mass Tumor Murder versus Serial Tumor Killing

Publisher： Karger

E-ISSN： 2296-5262|33|6|291-292

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.6, 2010-05, pp. : 291-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Serial profiling of circulating tumor DNA for optimization of anti‐VEGF chemotherapy in metastatic colorectal cancer patients

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1418-1426

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications

By  

Case Reports in Oncology, Vol. 3, Iss. 2, 2010-07 ,pp. : 282-286

Karger

Access to resources Recommend Favorite

Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 6, 2015-06 ,pp. : 998-1003

John Wiley & Sons Inc

Access to resources Recommend Favorite

Thymidylate synthase expression in circulating tumor cells: A new tool to predict 5‐fluorouracil resistance in metastatic colorectal cancer patients

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1397-1405

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumor Growth Control by Oral Trofosfamide in Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 1, 1998-03 ,pp. : 52-56

Karger

Access to resources Recommend Favorite